Prevention of T1D in NOD mice by i.n. gliadin was associated with an increased proportion of CD4+Foxp3+ and even more significant increase of γδ T cells specifically in the mucosal lymphoid compartments, but not in systemic lymphoid organs such as spleen and ILN (Fig. 4 and 5). The gene discussed is CD4; the disease is type 1 diabetes mellitus.